407 related articles for article (PubMed ID: 27109493)
1. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
2. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India.
Haile DB; Ayen WY; Tiwari P
Ethiop J Health Sci; 2013 Mar; 23(1):39-48. PubMed ID: 23559837
[TBL] [Abstract][Full Text] [Related]
4. Frequency and cost of serious adverse drug reactions in a department of general medicine.
Moore N; Lecointre D; Noblet C; Mabille M
Br J Clin Pharmacol; 1998 Mar; 45(3):301-8. PubMed ID: 9517375
[TBL] [Abstract][Full Text] [Related]
5. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India.
Sharma A; Kumari KM; Manohar HD; Bairy KL; Thomas J
Perspect Clin Res; 2015; 6(2):109-15. PubMed ID: 25878957
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reaction profile of microtubule-damaging antineoplastic drugs: A focused pharmacovigilance study in India.
Manohar HD; Adiga S; Thomas J; Sharma A
Indian J Pharmacol; 2016; 48(5):509-514. PubMed ID: 27721535
[TBL] [Abstract][Full Text] [Related]
7. Pharmacovigilance Study of Anticancer Drugs in a Tertiary Care Teaching Hospital in North India: A Retrospective Study.
Kumar R; Jindal A; Garg P; Kaur A; Kumar S; Tilak Raj R; Singh S
Cureus; 2023 Sep; 15(9):e44984. PubMed ID: 37822427
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions in a medical ward.
Wu FL; Yang CC; Shen LJ; Chen CY
J Formos Med Assoc; 1996 Mar; 95(3):241-6. PubMed ID: 8857258
[TBL] [Abstract][Full Text] [Related]
9. Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.
Mouton JP; Njuguna C; Kramer N; Stewart A; Mehta U; Blockman M; Fortuin-De Smidt M; De Waal R; Parrish AG; Wilson DPK; Igumbor EU; Aynalem G; Dheda M; Maartens G; Cohen K
Medicine (Baltimore); 2016 May; 95(19):e3437. PubMed ID: 27175644
[TBL] [Abstract][Full Text] [Related]
10. Descriptive study of adverse drug reactions in a tertiary care pediatric hospital in México from 2014 to 2017.
Morales-Ríos O; Cicero-Oneto C; García-Ruiz C; Villanueva-García D; Hernández-Hernández M; Olivar-López V; Jiménez-Juárez RN; Jasso-Gutiérrez L
PLoS One; 2020; 15(3):e0230576. PubMed ID: 32208451
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of adverse drug reactions at a private tertiary care hospital in south India.
Sriram S; Ghasemi A; Ramasamy R; Devi M; Balasubramanian R; Ravi TK; Sabzghabaee AM
J Res Med Sci; 2011 Jan; 16(1):16-25. PubMed ID: 21448378
[TBL] [Abstract][Full Text] [Related]
12. Comparison of adverse drug reactions detected by pharmacy and medical records departments.
Johnstone DM; Kirking DM; Vinson BE
Am J Health Syst Pharm; 1995 Feb; 52(3):297-301. PubMed ID: 7749958
[TBL] [Abstract][Full Text] [Related]
13. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward.
van Kraaij DJ; Haagsma CJ; Go IH; Gribnau FW
Neth J Med; 1994 May; 44(5):166-73. PubMed ID: 8028691
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological investigation of emergency infusion adverse drug reactions in Nanjing, China: a prospective cross-sectional study.
Cao Y; Hao W; Wu Y; Qiao J; Xie M; Jin H; Zhang J; Sun G; Sun H
Expert Opin Drug Saf; 2023; 22(9):871-879. PubMed ID: 37294710
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoepidemiology of adverse drug reactions in hospitalized patients with human immunodeficiency virus disease.
Harb GE; Alldredge BK; Coleman R; Jacobson MA
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):919-26. PubMed ID: 8315576
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with preventable adverse drug reactions.
Pearson TF; Pittman DG; Longley JM; Grapes ZT; Vigliotti DJ; Mullis SR
Am J Hosp Pharm; 1994 Sep; 51(18):2268-72. PubMed ID: 7801987
[TBL] [Abstract][Full Text] [Related]
17. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients.
Vázquez-Alvarez AO; Brennan-Bourdon LM; Rincón-Sánchez AR; Islas-Carbajal MC; Huerta-Olvera SG
BMC Pharmacol Toxicol; 2017 Dec; 18(1):79. PubMed ID: 29216902
[TBL] [Abstract][Full Text] [Related]
18. Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability.
Ithnin M; Mohd Rani MD; Abd Latif Z; Kani P; Syaiful A; Nor Aripin KN; Tengku Mohd TAM
JMIR Mhealth Uhealth; 2017 May; 5(5):e78. PubMed ID: 28559222
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors.
Pérez-Ingidua C; Rivas-Paterna AB; González-Perrino C; Aleo-Luján E; Ascaso-Del-Rio A; Laredo-Velasco L; Portolés-Pérez A; Vargas-Castrillón E
BMC Pediatr; 2024 May; 24(1):344. PubMed ID: 38760745
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda.
Kuteesa J; Nasasira M; Kiguba R
Expert Opin Drug Saf; 2024 Jan; 23(1):129-136. PubMed ID: 37552628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
